Price T Rowe Associates Inc Cardiovascular Systems Inc Transaction History

Price T Rowe Associates Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$13.31 - $19.86 $6,269 - $9,354	471 Added 2.45%	19,712 $392,000
Q4 2022 Feb 14, 2023	BUY	$12.74 - $15.12 $11,860 - $14,076	931 Added 5.08%	19,241 $262,000
Q3 2022 Nov 14, 2022	BUY	$12.93 - $17.17 $30,424 - $40,401	2,353 Added 14.75%	18,310 $254,000
Q2 2022 Aug 15, 2022	BUY	$13.53 - $23.34 $5,046 - $8,705	373 Added 2.39%	15,957 $229,000
Q1 2022 May 16, 2022	BUY	$16.14 - $22.6 $12,815 - $17,944	794 Added 5.37%	15,584 $352,000
Q4 2021 Feb 14, 2022	SELL	$18.64 - $36.77 $11,612 - $22,907	-623 Reduced 4.04%	14,790 $278,000
Q3 2021 Nov 15, 2021	SELL	$32.83 - $43.0 $2,462 - $3,225	-75 Reduced 0.48%	15,413 $506,000
Q2 2021 Aug 16, 2021	BUY	$34.41 - $44.03 $26,426 - $33,815	768 Added 5.22%	15,488 $661,000
Q1 2021 May 17, 2021	SELL	$37.29 - $47.19 $40,273 - $50,965	-1,080 Reduced 6.84%	14,720 $564,000
Q4 2020 Feb 16, 2021	BUY	$34.3 - $44.09 $541,940 - $696,622	15,800 New	15,800 $691,000

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.